Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
January 18, 2019 - The FDA announced the discontinuation of Leadiant Biosciences’ Adagen (pegademase bovine) 375 units/1.5 mL injection.
Return to publications